Does IDURSULFASE Cause Tonsillar hypertrophy? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Tonsillar hypertrophy have been filed in association with IDURSULFASE (ELAPRASE). This represents 0.6% of all adverse event reports for IDURSULFASE.
18
Reports of Tonsillar hypertrophy with IDURSULFASE
0.6%
of all IDURSULFASE reports
0
Deaths
17
Hospitalizations
How Dangerous Is Tonsillar hypertrophy From IDURSULFASE?
Of the 18 reports, 17 (94.4%) required hospitalization, and 1 (5.6%) were considered life-threatening.
Is Tonsillar hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IDURSULFASE. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does IDURSULFASE Cause?
Pyrexia (524)
Product dose omission issue (450)
Inappropriate schedule of product administration (371)
Cough (263)
Infusion related reaction (241)
Pneumonia (232)
Death (222)
Dyspnoea (202)
Influenza (200)
Covid-19 (197)
What Other Drugs Cause Tonsillar hypertrophy?
ADALIMUMAB (151)
ONDANSETRON (51)
SOMATROPIN (43)
SECUKINUMAB (42)
DUPILUMAB (39)
METHOTREXATE (39)
INFLIXIMAB (31)
TACROLIMUS (26)
INFLIXIMAB-DYYB (25)
ETANERCEPT (24)
Which IDURSULFASE Alternatives Have Lower Tonsillar hypertrophy Risk?
IDURSULFASE vs IFOSFAMIDE
IDURSULFASE vs IGURATIMOD
IDURSULFASE vs ILOPERIDONE
IDURSULFASE vs ILOPROST
IDURSULFASE vs IMATINIB